The Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests (CDLTs) is holding a public meeting on Monday, September 25, 2017. The Panel will discuss calendar year 2018 clinical laboratory fee schedule codes for which CMS received no applicable information to calculate a Medicare payment rate. The list of CDLTs that will be discussed during the meeting is available here. During the meeting the Panel will consider public recommendations on whether the codes should be included on the CLFS, and if so, what method of payment should be used to price the test codes (crosswalking or gapfilling). The agenda with webcast and call-in information is posted here.
The Trump Administration is proposing to once again push back the effective date of a January 2017 final rule making changes to the calculation of the 340B “ceiling price” that may be charged to covered entities and related civil money penalties. As previously reported, while implementation of this rule has already been delayed until October 1, 2017, the Health Resources and Services Administration (HRSA) now proposes to delay the effective date to July 1, 2018. According to HRSA, this delay is necessary “to allow a more deliberate process of considering alternative and supplemental regulatory provisions and to allow for sufficient time for additional rulemaking.” Comments will be accepted until September 20, 2017.
The Senate Committee on Health, Education, Labor, and Pensions is holding a series of hearings in September 2017 to focus on “actions Congress should take to stabilize and strengthen the individual health insurance markets.” Specifically, a September 6 hearing will feature five state insurance commissioners, and second hearing on September 7 will include testimony from five governors. Additional bipartisan hearings on the individual insurance market are planned, but details have not yet been announced.
CMS is hosting a call on September 6, 2017 to discuss Medicare Spending per Beneficiary Post-Acute Care (PAC) resource use measures, which are mandated by the Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act). The call will focus on the components of each measure and public reporting. The target audience for the call includes: PAC providers (skilled nursing facilities, home health agencies, inpatient rehabilitation facilities, and long-term care hospitals), health care industry professionals, clinicians, researchers, health IT vendors, and other interested stakeholders.
On September 19, 2017, CMS is hosting a call to explain Qualified Medicare Beneficiary (QMB) billing rules, including upcoming changes to the HIPAA Eligibility Transaction System (HETS) and remittance advice to identify patient QMB status and exemption from cost-sharing.
CMS has published its final rule to update the Medicare acute hospital inpatient prospective payment system (IPPS) and long-term care hospital (LTCH) prospective payment system (PPS) for fiscal year (FY) 2018.
Acute Hospital Rate & Policy Updates
CMS projects that the rate and policy changes in the rule will increase total IPPS payments by about $2.4 billion in FY 2018 compared to FY 2017 levels. Rate adjustments in the rule include: a 2.7 market basket update reduced by a -0.6% multifactor productivity adjustment and a 0.75% cut mandated by the Affordable Care Act (ACA); a -0.6% adjustment related to the 2017 two midnight policy; and a +0.4588% documentation and coding adjustment under the 21st Century Cures Act. CMS also made changes to uncompensated care payments that are expected to increase IPPS operating payments by another 0.8%.
Actual updates to a hospital depend on several quality-related adjustments. The potential updates to standardized amounts for FY 2018 range from a high of 1.35% for a hospital that submits quality data under the Hospital Inpatient Quality Reporting (IQR) Program and is a meaningful Electronic Health Record (EHR) user, to a low of -1.35% for a hospital that does not submit quality data and is not a meaningful EHR user. Specific hospital payments also can be impacted by other factors, including penalties for excess readmissions under the Hospital Readmissions Reduction Program (HRRP), poor performance under the Hospital-Acquired Condition Reduction Program, and bonuses and penalties under the Hospital Value-Based Purchasing Program. For instance, CMS estimates that 2,577 hospitals will have their base operating MS-DRG payments reduced under the HRRP program in FY 2018, saving approximately $556 million in FY 2018. The final rule also updates these hospital quality programs, including revisions to HRRP policies to account for a hospital’s proportion of patients who are dually eligible for Medicare and Medicaid (as a proxy for socio-economic status), applicable to discharges beginning in FY 2019. Continue Reading
CMS has finalized fiscal year (FY) 2018 Medicare hospice reimbursement rates and other updates to Medicare hospice policies. As mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), CMS is increasing FY 2018 hospice rates by 1% (approximately $180 million) for those hospices that submit required quality data; this update is reduced by 2 percentage points for hospices that fail to report required quality data. Under the final rule, the FY 2018 hospice cap is $28,689.04. The final rule also makes various updates to the Hospice Quality Reporting Program and discusses details of CMS’s plans to begin public reporting of hospice quality measures on a Hospice Compare Site (for additional information on Hospice Compare, see the related CMS fact sheet).
In the May 3, 2017 proposed rule, CMS discussed a potential proposal for a regulatory text change at 42 CFR § 418.25 that would clarify that documentation used for the initial certification of a patient’s terminal illness must come from the referring physician’s or acute/post-acute care facility’s medical records. In the final rule, CMS briefly addresses public feedback it received on this issue. CMS reiterates that it is not proposing any regulatory changes at this time. The agency will, however, follow up on commenters’ observation that the regulations at 42 CFR 418.22(b) already require that the patient’s prognosis and certification of terminal illness be supported by clinical information and other documentation. That is, CMS will work with Medicare Administrative Contractors “to confirm whether they are requesting such information when claims are selected for medical review and, if not, whether such information should be included in any additional documentation requests.” Furthermore, CMS “continue[s] to encourage providers to use the full range of clinical documentation when certifying terminal illness in order to ensure physician engagement and accountability.”
Signals Trump Administration’s About-Face on Obama-Era Mandatory Innovation Models
The Centers for Medicare & Medicaid Services (CMS) has just released a proposed rule to cancel a significant — but still-pending — Obama Administration program that would require certain hospitals to participate in Medicare episode payment models (EPMs) for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), and surgical hip/femur fracture treatment (SHFFT) procedures furnished in designated areas of the country. Perhaps more surprisingly, CMS also would dramatically scale back mandatory participation in the ongoing Comprehensive Care for Joint Replacement (CJR) program, with an option for participating hospitals in about half of the current CJR locations to shift to voluntary participation.
As previously reported, the EPM and CJR programs were part of the Obama Administration’s high-profile efforts to move the Medicare system away from fee-for-service (FFS) payments and towards alternative payment models (APMs) that reward quality of care rather than volume of services. Although early APMs (e.g., the Bundled Payment for Care Initiative) were voluntary, CMS eventually shifted attention to mandatory models in order to broaden participation. President Trump’s Secretary of Health and Human Services, Tom Price, M.D., has long been critical of mandatory Medicare payment innovation models and has been contemplating changes to these programs. It is now clear that the Trump Administration is reversing course and pulling back from mandatory models. In fact, CMS stated in an announcement that it “expects to increase opportunities for providers to participate in voluntary initiatives rather than large mandatory episode payment model efforts” in the future.
EPM/CR Models Slated for Cancellation
CMS published a final rule in early 2017 to establish a mandatory EPM program for AMI and CABG cases in 98 metropolitan statistical areas (MSA), along with a mandatory EPM program for SHFFT procedures in 67 MSAs covered by the CJR program. In short, CMS planned to provide a bundled payment to hospitals in selected geographic areas for individual episodes, covering all services provided during the inpatient admission through 90 days post-discharge. In such cases, the hospital would be held accountable for spending during the episode of care. The bundled payment to the hospital would be paid retrospectively through a reconciliation process (hospitals and other providers and suppliers would continue to submit claims and receive payment via the usual Medicare FFS payment systems). A participant hospital would receive a “reconciliation payment” if its actual episode payments (combined Medicare Part A and B claims payments for services furnished to the beneficiary during the episode) were below the target price for the episode, and certain quality thresholds were met. Beginning with the second performance year, affected hospitals would be required to repay Medicare for a portion of spending that exceeded the target price (with limits on upward and downward adjustment). The rule also included provisions intended to promote the use of cardiac rehabilitation services through a Cardiac Rehabilitation (CR) Incentive Payment Model. Continue Reading
CMS has published a notice with comment period updating prospective payment system (PPS) rates for Medicare services furnished by inpatient psychiatric facilities (IPFs) during fiscal year (FY) 2018. CMS estimates that its policies will increase payments by $45 million (0.99%) compared to FY 2017 levels. This increase is based on 1.25% payment rate update, offset by a 0.26 percentage point reduction due to the outlier fixed-dollar loss threshold adjustment. The FY 2018 IPF PPS per diem will rise from $761.37 in FY 2017 to $771.35 in FY 2018; providers that fail to meet quality data reporting requirements will receive a FY 2018 per diem rate of $756.11. The fixed dollar loss threshold amount also will increase, from $10,120 in FY 2017 to $11,425 in FY 2018. The notice does not include substantive changes in policy.
As it has in other recent Medicare payment rulemaking, CMS solicits comments on ways the agency can “increase quality of care, lower costs improve program integrity, and make the health care system more effective, simple and accessible.” CMS will accept comments until October 6, 2017.
The Centers for Medicare & Medicaid Services (CMS) has once again extended for six months its “temporary” moratoria on the Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) enrollment of new nonemergency ground ambulance suppliers and home health agencies (HHAs) in selected states, effective July 29, 2017. The moratoria on new HHA enrollment (including new subunits and branch locations) applies to Florida, Illinois, Michigan, and Texas, while the moratoria on enrollment of non-emergency ground ambulance providers and suppliers applies to New Jersey, Pennsylvania, and Texas. According to CMS, the “circumstances warranting the imposition of the moratoria have not yet abated,” and the moratoria are still needed as it monitors indicators and continues taking administrative actions (e.g., payment suspensions and revocations of provider/supplier numbers). Since CMS imposed the moratoria on July 31, 2013, the agency has denied enrollment to 1184 HHAs and 23 ambulance companies in the affected geographic areas.
CMS has finalized Medicare prospective payment system (PPS) rates for inpatient rehabilitation facility (IRF) services for fiscal year (FY) 2018, which begins October 1, 2017. CMS estimates that IRF PPS payments will increase by 0.9% overall ($75 million) under the final rule compared to FY 2017 levels. As mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), CMS adopted a 1.0% increase factor for FY 2018 (note that an IRF that does not submit required quality data is subject to a 2.0 percentage point decrease in its annual update). The final FY 2018 standard payment conversion factor is $15,838, compared to $15,708 for FY 2017. The final FY 2018 outlier threshold for high-cost cases is $8,679, compared to $7,984 in FY 2017 (which has the effect of decreasing aggregate payments by about 0.1%). CMS also updated the IRF wage index and case-mix group relative weights in a budget-neutral manner. CMS did not revise facility-level adjustment factors; CMS will continue to monitor the effects of FY 2014 adjustments.
In the final rule, CMS revised the lists of ICD–10–CM diagnosis codes that are used to determine presumptive compliance with the patient classification requirement that at least 60% of a facility’s patient population have one of 13 qualifying conditions. In addition, CMS adopted its proposed subregulatory process for adopting changes to the ICD–10–CM medical code data set for the presumptive methodology lists. CMS also summarized responses to its solicitation of comments on potential reforms to the 60% rule, which CMS intends to consider as it explores “ways to modernize the Medicare program.”
Furthermore, CMS adopted its proposal to eliminate the 25% payment penalty that applies to late IRF patient assessment instrument (IRF-PAI) submissions and remove the voluntary swallowing status item from the IRF PAI. CMS also revised and updated quality measures and reporting requirements under the IRF quality reporting program.
CMS has released its final rule to update Medicare skilled nursing facility (SNF) prospective payment system (PPS) rates and policies for FY 2018, which begins October 1, 2017. The final rule incorporates a 1% increase to SNF PPS rates as mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); in the absence of MACRA, the update would have been 2%. CMS estimates that the final rule will increase overall payments to SNFs by $370 million compared to FY 2017 levels (note that in the proposed rule, CMS forecast that the 1% increase would result in a $390 million increase, but CMS scaled back its estimate due to an updated baseline spending figure). A 2% reduction is applied to the update for SNFs that fail to submit required quality measures data.
The final rule also addresses a variety of other SNF PPS policies. Among other things, the rule: revises and rebases the SNF market basket index; revises quality measures and reporting requirements for the SNF Quality Reporting Program (QRP); finalizes requirements for the SNF Value Based Purchasing Program (which applies to services furnished on or after October 1, 2018); and revises the regulatory requirements for survey team composition for the purposes of investigating a complaint and on-site monitoring of compliance.
As previously reported, CMS is contemplating more significant reforms of the SNF PPS methodology (the Resident Classification System or RCS) to begin as early as FY 2019. Those reforms have not yet been formally proposed, and CMS does not substantively discuss the potential RCS framework in the final FY 2018 rule.
A multi-year Republican drive to repeal the Affordable Care Act (ACA) hit a significant roadblock in the early hours of July 28, 2017 when the Senate was unable to muster the votes to pass any form of ACA repeal or repeal/replace legislation – even a stripped down, so-called “skinny” version of HR 1628 offered by Senate Majority Leader Mitch McConnell. McConnell’s plan, which essentially would have served as a placeholder to keep the legislative process moving, would have eliminated the penalties associated with the mandates that most individuals purchase insurance and certain employers offer insurance, extended the medical device tax moratorium, and made other very limited changes to the law. While House Speaker Paul Ryan expressed a willingness to give the Senate an opportunity to conference with the House on additional modifications to the bill, it was not enough to secure passage, and the McConnell amendment failed on a 49-51 vote.
The path ahead is uncertain at this point, given the deep policy divisions within the Republican Party regarding the nature of changes that should be made to the ACA (and given the unanimous Democratic opposition to the ACA repeal/reform bills advanced by Republican leaders to date). While revisions to the ACA – even bipartisan improvements considered through the committee process – could be considered in the future, right now there does not appear to be a clear way forward for ACA reform. The first test may be whether Republicans will accept Senate Minority Leader Charles Schumer’s request that a bipartisan effort be made to strengthen insurance markets.
CMS has issued a proposed rule establishing a methodology to reduce state Medicaid disproportionate share hospital (DSH) allotments annually beginning with fiscal year (FY) 2018, as mandated by the Affordable Care Act (and modified in subsequent legislation). CMS estimates that the rule would reduce state DSH allotments/payments by $43 billion for the period of FY 2018 through FY 2025, and the agency anticipates that the rule would reduce total federal financial participation claimed by states by similar amounts. CMS will accept comments on the proposed rule until August 28, 2017.
CMS is proposing to cut CY 2018 Medicare home health prospective payment system (HH PPS) payments by 0.4% — or $80 million overall — compared to 2017 rates under a proposed rule published on July 28, 2017. Furthermore, the agency plans major revisions to the HH PPS case-mix methodology for 2019 that potentially could cut payments by as much as $950 million (-4.3%) in 2019. CMS will accept comments on the proposed rule until September 25, 2017.
With regard to 2018 payments, CMS is proposing a 1% update percentage as mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for those home health agencies (HHAs) that report required quality data (otherwise the update is decreased by 2 percentage points). The update percentage is more than offset by other policies in the proposed rule, however, including a 0.5% reduction due to the sunset of the rural add-on provision and a – 0.97% adjustment for nominal case-mix coding intensity growth (the last year of a three-year phase in period). The proposed CY 2018 national, standardized 60-day episode payment rate would be $3,038.43, compared to $2,989.97 for 2017; the rate for an HHA that does not submit required quality data would be $2,978.26. CMS also proposes to, among other things: recalibrate HH PPS case-mix weights; update the home health wage index; update measures included in the Home Health Quality Reporting Program; remove or modify 35 current Outcome and Assessment Information Set (OASIS) items effective January 1, 2019; and refine requirements under the Home Health Value-Based Purchasing Model.
Looking ahead to 2019, CMS is proposing to adopt case-mix methodology refinements through implementation of a Home Health Groupings Model (HHGM), which CMS believes classifies care “in a manner consistent with how clinicians differentiate between patients and the primary reason for needing home health care.” The HHGM uses 30-day periods of care rather than the 60-day episode now used. According to CMS, the HHGM eliminates the use of the number of therapy visits provided to determine payment, relying more heavily on clinical characteristics and other patient information (e.g., diagnosis, functional level, comorbid conditions, admission source) to place patients into one of 144 payment groups. CMS would use a Cost-Per-Minute plus Non-Routine Supplies approach to measure costs, using information from the Medicare cost report (rather than current weighted minutes of care using Bureau of Labor Statistics data). CMS seeks comments on all aspects of the proposed HHGM, including whether CMS should: Continue Reading
Rule Would Delay Appropriate Use Criteria Requirement until 2019, Cut Rates for Off-Campus Hospital Departments
The Centers for Medicare & Medicaid Services (CMS) has published its proposed rule to update the Medicare physician fee schedule (PFS) for calendar year (CY) 2018. The proposed rule addresses numerous Medicare policies, including: implementation of appropriate use criteria (AUC) for advanced diagnostic imaging services; a deep reduction in reimbursement for off-campus hospital outpatient departments; and consideration of potentially misvalued codes, among many others. Highlights of the proposed rule include the following:
- Under the proposed rule, the 2018 MPFS conversion factor (CF) would be $35.9903, up slightly from the 2017 CF of $35.8887. This update reflects a 0.5% update factor specified under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which is partially offset by a -0.03% relative value unit (RVU) budget neutrality adjustment and a -0.19% “target recapture amount” (since savings from proposed revisions to the RVUs of misvalued codes would not meet a statutory-0.5% target).
- CMS proposes to revise a policy adopted in the final 2017 Medicare Hospital Outpatient Prospective Payment System (OPPS) rule to implement Section 603 of the Bipartisan Budget Act of 2015, which establishes a site-neutral payment policy for certain newly-acquired, provider-based, off-campus hospital outpatient departments (which CMS calls “off-campus provider-based departments” or “off-campus PBDs”). Effective for services provided on or after January 1, 2017, off-campus PBDs are paid under the PFS in most cases, rather than the generally higher-paying OPPS (with certain exceptions). In the 2017 rule, CMS established new PFS site-of-service payment rates to pay non-excepted off-campus PBDs for the technical component of non-excepted services; these rates generally are based on OPPS payments scaled downward by 50% (called the PFS Relativity Adjuster). For CY 2018, CMS is proposing to reduce the Relativity Adjuster by 50%; that is, the technical component rates for these services would be reduced from 50% of the OPPS rate to 25% of the OPPS rate. CMS invites comments on whether a different PFS Relatively Adjuster would be appropriate.
While the Capitol Hill spotlight is focused on the Senate debate on legislation to repeal or revise the Affordable Care Act, the House of Representatives quietly approved by voice vote HR 3178, the Medicare Part B Improvement Act of 2017. The bipartisan bill would impact a number of Medicare policies, including the Stark physician self-referral law, home infusion therapy and dialysis service policies, and documentation requirements for orthotics and prosthetics. In particular, the bill would: Continue Reading
CMS has published its proposed rule to update Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system rates and policies for calendar year (CY) 2018. In addition to proposing rate updates for the two payment systems, CMS solicits comments on a wide range of topics, including, among others: deep OPPS reimbursement cuts for drugs obtained through the 340B drug discount program; a new OPPS drug administration packaging proposal along with a broader query regarding the need for packaging policy reforms; a proposal to allow total knee replacement procedures to be performed on an outpatient basis; and potential changes to the way CMS calculates the ASC payment update. CMS will accept comments on the proposed rule until September 11, 2017.
With regard to OPPS payments, CMS proposes a 1.75% update for 2018, reflecting a 2.9% market basket increase, which is partly offset by a 0.75 percentage point reduction and a 0.4% multi-factor productivity (MFP) reduction. CMS expects that overall OPPS payments would increase by 2% ($897 million) compared to 2017 levels (although this estimate does not include the effects its 340B drug proposal, discussed below). The update for hospitals that fail to meet the Hospital Outpatient Quality Reporting (OQR) Program reporting requirements is reduced by 2.0 percentage points. Rate updates for individual procedures vary based on changes in ambulatory payment classification (APC) assignments and other proposed policies.
Other major provisions of the proposed rule include the following: Continue Reading
The CMS Chief Actuary has officially determined that the projected Medicare per capita growth rate will not exceed the target that would require the Independent Payment Advisory Board (IPAB) to submit plans to reduce 2019 Medicare per-capita spending. Under the Affordable Care Act, if the threshold is breached, IPAB must submit detailed Medicare spending cut proposals to Congress and the President; IPAB’s proposals would go into effect automatically unless Congress enacts alternative legislation to achieve the required savings (with certain exceptions). The IPAB spending control mechanism is deeply unpopular, even though the Board has never been formally constituted nor has the savings target ever been triggered. There have been numerous legislative attempts to repeal the IPAB authority, and President Trump has called for repeal of IPAB in his FY 2018 budget proposal.
CMS has made numerous technical and typographical corrections to its October 4, 2016 final rule revising the requirements that long-term care facilities must meet to participate in the Medicare and Medicaid programs. CMS notes that the corrections are consistent with the policy discussion in the final rule and do not result in substantive policy changes. The corrections are effective July 13, 2017.